Abata Therapeutics

Abata Therapeutics is a clinical-stage biotech company dedicated to transforming lives with Treg therapies for severe autoimmune and inflammatory diseases. Founded by pioneers in Treg biology, TCR and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers, Abata has developed a differentiated product engine to create a pipeline of novel engineered Treg cell therapies that are tissue-specific, robust, and durable. Abata’s lead programs are in progressive multiple sclerosis and type 1 diabetes – tissue-specific autoimmune diseases with substantial unmet need, supporting a strong rationale for Abata’s Treg approach. Abata is based in Watertown, Mass.